EIF4B and cervical carcinoma: Depletion of eIF-4B using silencing RNA in the human cervical cancer line HeLa reduced proliferation by greater than 90% over a five day period and rendered them more sensitive to killing by the topoisomerase inhibitor camptothecin [40].